Related Experiment Video
Updated: Jul 20, 2026
10:39
Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
Distribution of CTLA-4 polymorphisms in allergic asthma
Monika Jasek1, Wioleta Łuszczek, Andrzej Obojski
1Laboratory of Immunogenetics, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland.
International Archives of Allergy and Immunology
|August 24, 2006
Summary
Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) gene polymorphisms were investigated in relation to allergic asthma risk. This study found no significant association, suggesting CTLA-4 variants are not a risk factor for allergic asthma in the Polish population.
Area of Science:
- Immunogenetics
- Allergology
- Molecular Biology
Background:
- Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) is a key negative regulator of T-cell activation.
- CTLA-4 gene variations have been linked to allergic conditions, but findings for asthma remain controversial.
- Genetic associations require further investigation in diverse populations.
Purpose of the Study:
- To investigate the association between specific CTLA-4 gene polymorphisms and allergic asthma.
- To determine if CTLA-4 single nucleotide polymorphisms (SNPs) and microsatellite variations confer risk for allergic asthma in a Polish cohort.
Main Methods:
- Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) was used to analyze three CTLA-4 SNPs (-1147 C/T, -318 C/T, +49 A/G).
- Microsatellite polymorphism ((AT)(n)) in the CTLA-4 gene was also assessed.
- The study included 219 Polish patients with allergic asthma and 102 healthy controls.
Main Results:
- No statistically significant differences were observed in the allele, genotype, or haplotype frequencies of the studied CTLA-4 SNPs and microsatellite polymorphism between allergic asthma patients and healthy controls.
- The distribution of genetic variants did not reveal a correlation with allergic asthma in the examined population.
Conclusions:
- CTLA-4 gene polymorphisms do not appear to be a significant risk factor for developing allergic asthma in the Polish population.
- Further research may be needed to explore other genetic or environmental factors contributing to allergic asthma pathogenesis.
Related Concept Videos
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
01:22T Cell Activation and Clonal Selection
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.